Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

100%(3 trials)

Terminated

1(25%)

Phase Distribution

Ph not_applicable

25%

Ph phase_2

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

3(75.0%)

N/ANon-phased studies

1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Detailed Status

Completed3

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 2

Trials by Phase

Phase 23 (75.0%)

N/A1 (25.0%)

Trials by Status

completed375%

terminated125%

Recent Activity

0 active trials

Showing 4 of 4

completednot_applicable

The Ondansetron Premedication Trial in Juvenile Idiopathic Arthritis

NCT04169828

completedphase_2

Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

NCT02379091

terminatedphase_2

Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α Blockers

NCT01217814

completedphase_2

Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis

NCT01900431

Clinical Trials (4)

Showing 4 of 4 trials

NCT04169828Not Applicable

The Ondansetron Premedication Trial in Juvenile Idiopathic Arthritis

Completed

NCT02379091Phase 2

Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

Completed

NCT01217814Phase 2

Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α Blockers

Terminated

NCT01900431Phase 2

Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4